2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theLiver Cancer Diagnostics Market from 2025 to 2034?
The increase in liver cancer cases is anticipated to fuel the expansion of the liver cancer diagnostics market. Liver cancer happens when the cells in the liver multiply uncontrollably, leading to a fatal disease. Diagnostic tests for liver cancer are used to check if cancer cells are propagating within the liver or surrounding it after the identification of initial liver carcinoma, thereby augmenting the liver cancer diagnostics market. For instance, the American Cancer Society, a voluntary health organization in the US, reported in their Cancer Facts & Figures 2023, issued in January 2023, that new cases of liver and intrahepatic bile duct cancer in females went up to 13,230 in 2023, a rise from 12,640 in 2020, in the United States. Additionally, in 2023, about 41,210 fresh liver cancer cases are projected to be identified in the US, with an estimated 29,380 expected fatalities. Consequently, the escalating prevalence of liver cancer is triggering the development of the liver cancer diagnostic market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10481&type=smp
#How Does the ProjectedLiver Cancer Diagnostics Market Growth Compare Over the Forecast Period?
In recent years, there has been a robust expansion in the liver cancer diagnostics market size. This market is projected to accelerate from $9.69 billion in 2024 to $10.4 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The progress noted in the historic period is accredited to advancements in biopsy methods and histopathology, the emergence of biomarker detection, the promotion of screening programs, breakthroughs in genetic testing, and advancements in liver imaging modalities.
The market size for liver cancer diagnostics is predicted to experience robust growth over the next several years, expanding to “$13.86 billion by 2029 with a compound annual growth rate (CAGR) of 7.4%. This upward projection during the forecast period can be ascribed to regulatory reforms and standardization efforts, increasing significance of imaging modalities, the advent of next-generation sequencing, wider screening programs and heightened awareness, and a surging demand for biomarker-based tests. The forecast period will also likely witness key trends such as a rise in occurrence and prevalence, advancements in imaging technologies, emphasis on non-invasive diagnostics, precision and personalized diagnostics, and the incorporation of artificial intelligence (AI).
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10481
How Are Market Trends and Innovations Revolutionizing theLiver Cancer Diagnostics Industry in Recent Times?
In an effort to boost diagnostic accuracy and facilitate early detection, leading businesses that are active in the liver cancer diagnostics market are innovating biomarker-based assays and algorithms. These diagnostic tools utilize distinct biological markers for disease identification, thereby delivering more specific and efficient diagnostic results. For example, in November 2023, the biotech firm, Roche Diagnostics, from the US, introduced the Elecsys PIVKA-II assay and Elecsys GAAD algorithm. The Elecsys PIVKA-II assay identifies heightened levels of the PIVKA-II biomarker, linked with hepatocellular carcinoma (HCC), which enhances early liver cancer detection in patients with high risk. The Elecsys GAAD algorithm merges various diagnostic markers like PIVKA-II and AFP, in order to boost diagnostic accuracy and simplify decision-making during liver cancer detection.
Which Key Market Players Are Shaping the Future and Growth of theLiver Cancer Diagnostics Market?
Major companies operating in the liver cancer diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Qiagen NV, Thermo Fisher Scientific Inc., Siemens Healthineers, Illumina Inc., Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc., Danaher Corporation, Foundation Medicine Inc., Agilent Technologies Inc., Genemed Biotechnologies Inc., Merck KGaA, Fujifilm Medical Systems USA Inc., GE Healthcare, Advanced Cell Diagnostics Inc., Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon A/S, BioGenex Laboratories Inc., OncoCyte Corporation, Guardant Health Inc., Exact Sciences Corporation, Grail Inc., Freenome Holdings Inc., Natera Inc., Personal Genome Diagnostics Inc., Thrive Earlier Detection Corp
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report
#thebusinessresearchcompany #marketresearch #marketintelligence
The liver cancer diagnostics market covered in this report is segmented –
1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types
2) By Screening: Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings
3) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories
Subsegments:
1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma
2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma
3) By Hepatoblastoma: Pure Hepatoblastoma, Mixed Hepatoblastoma
4) Other Types: Secondary Liver Cancer, Fibrolamellar Carcinoma
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10481&type=smp
What Regions Are Dominating the Liver Cancer Diagnostics Market Growth?
North America was the largest region in the liver cancer diagnostics market in 2024. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Liver Cancer Diagnostics Maret 2025, By The Business Research Company:
Transplant Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report
Cervical Cancer Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report
Precision Medicine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
